Biopharma Asia

July/August 2026 | Volume 15 Issue 4

---

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

---

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

---

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

---

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

---

Amsphere A3

JSR Life Sciences

---